Home > Hyman Phelps McNamara > Offices > Office Profile


Hyman, Phelps & McNamara, P.C.

  - Office Profile
 





                  Firm Logo for Hyman Phelps McNamara P.C.
Hyman, Phelps & McNamara, P.C. 
Washington, District of Columbia Office
View all offices

700 Thirteenth Street, N.W., Suite 1200
Washington, District of Columbia  20005-5929


Telephone: 202-737-5600
Fax: 202-737-9329
http://www.hpm.com

Profile Visibility
#3 in weekly profile views out of 2,936 law firms in Washington, District of Columbia
#240 in weekly profile views out of 279,115 total law firms Overall


Office Hours:
Monday: 08:30 AM-06:30 PM
Tuesday: 08:30 AM-06:30 PM
Wednesday: 08:30 AM-06:30 PM
Thursday: 08:30 AM-06:30 PM
Friday: 08:30 AM-06:30 PM


About this office:

Hyman, Phelps & McNamara, P.C. is a law firm that advises and represents a broad range of clients on legal issues concerning food, drug, medical device and cosmetic law and regulation. To complement its core expertise in FDA matters, the firm also serves its clients in related areas, such as advertising, controlled substance regulation, health care fraud and abuse, reimbursement, pricing laws and government contracts. In 1980, three former U.S. Food and Drug Administration (FDA) lawyers opened the firm in Washington, D.C. to concentrate in this area of the law. Hyman, Phelps & McNamara, P.C. now has one of the most extensive food and drug practices in the United States.



 

Statement of Practice Summary:
Practice before all Courts, Government Agencies, International Regulatory Authorities involving Foods, Drugs, Cosmetics, Medical Devices, Biologics, Pesticides, Health Care, Controlled Substances and Consumer Products.

Documents by Lawyers at this office
Subscribe to this feed

A Second Company Asks FDA to Reconsider Denial of NCE Exclusivity for Approved FDC . . . and to Stay Application of the Agency’s New Interpretation
Kurt R. Karst, April 23, 2014
The battle over New Chemical Entity (“NCE”) exclusivity for Fixed-Dose Combination (“FDC”) drugs continues to heat up. In a recent Petition for Reconsideration and Petition for Stay (Docket No. FDA-2013-P-0119), Ferring Pharmaceuticals, Inc. (“Ferring”) requestes...

Proposed GMO Labeling Bill Would Block State Laws
Riëtte van Laack, April 21, 2014
Legislation that would require labeling of genetically engineered or bioengineered foods (generally referred to as “GMOs”) has been proposed in various states. If enacted, these state laws may expose companies to a patchwork of different GMO labeling requirements.

Zogenix Prevails in Initial Challenge to Massachusetts Emergency Order Banning ZOHYDRO ER
Kurt R. Karst, April 21, 2014
When we first heard about the Complaint and Motion for Preliminary Injunction Zogenix, Inc. filed against Massachusetts Governor Deval Patrick, among others, alleging that the Commonwealth’s ban on FDA-approved ZOHYDRO ER (hydrocodone bitartrate) Extended-release Capsules is unconstitutional...




Year Established: 1980


Return to the Hyman, Phelps & McNamara, P.C. Firm Overview


 

Complete a Client Review


Have you recently worked with this firm? Share your experience as a Client of this firm and complete a Client Review to help others make an informed choice when hiring legal counsel.
 
 

Compare this Firm

Compare this firm to other firms in your Favorites.
 

Add firm to Favorites

As a registered user of martindale.com Connected, you can add firms to your list of Favorites. You can securely add comments and compare the firms in your Favorites.